Company · CIK 1873835
Immix Biopharma, Inc.
| CIK | 1873835 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | IMMX (Nasdaq) |
| First annual or quarterly report | 2022-03-28 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-292665 | 2026-01-09 | 2026-09-29 | 5 | |
| 333-269100 | 2023-01-03 | 2025-12-08 | 8 | |
| 333-290725 | 2025-10-06 | 2025-12-01 | 2 | |
| 333-274684 | 2023-09-25 | 2023-09-28 | 2 | |
| 333-265292 | 2022-05-27 | 2022-07-19 | 2 | |
| 333-259591 | 2021-09-17 | 2021-12-17 | 7 |
Filings
28| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-29 | 424B5Shelf takedown | 333-292665 | 0001493152-26-044771 |
| 2026-05-21 | 424B5Shelf takedown | 333-292665 | 0001493152-26-024869 |
| 2026-03-25 | 424B5Shelf takedown | 333-292665 | 0001493152-26-012718 |
| 2026-01-22 | EFFECTDeclared effective | 333-292665 | 9999999995-26-000261 |
| 2026-01-09 | S-3Shelf registered | 333-292665 | 0001493152-26-001159 |
| 2025-12-08 | 424B5Shelf takedown | 333-269100 | 0001493152-25-026694 |
| 2025-12-01 | EFFECTDeclared effective | 333-290725 | 9999999995-25-003437 |
| 2025-10-06 | S-3Shelf registered | 333-290725 | 0001493152-25-016975 |
| 2025-06-03 | 424B5Shelf takedown | 333-269100 | 0001641172-25-013418 |
| 2024-02-07 | 424B5Shelf takedown | 333-269100 | 0001493152-24-005276 |
| 2024-02-05 | 424B5Shelf takedown | 333-269100 | 0001493152-24-004935 |
| 2023-09-28 | EFFECTDeclared effective | 333-274684 | 9999999995-23-002826 |
| 2023-09-25 | S-3Shelf registered | 333-274684 | 0001493152-23-033593 |
| 2023-07-14 | 424B5Shelf takedown | 333-269100 | 0001493152-23-024628 |
| 2023-03-22 | 424B5Shelf takedown | 333-269100 | 0001493152-23-008486 |
| 2023-01-11 | EFFECTDeclared effective | 333-269100 | 9999999995-23-000088 |
| 2023-01-03 | S-3Shelf registered | 333-269100 | 0001493152-23-000127 |
| 2022-07-19 | RWWithdrawn | 333-265292 | 0001493152-22-019743 |
| 2022-05-27 | S-1Registration filed | 333-265292 | 0001493152-22-015370 |
| 2022-05-24 | DRSDraft made public | 377-06207 | 0001493152-22-014852 |
| 2021-12-17 | 424B4Final prospectus | 333-259591 | 0001493152-21-031880 |
| 2021-12-15 | EFFECTDeclared effective | 333-259591 | 9999999995-21-004700 |
| 2021-11-04 | S-1/AAmendment | 333-259591 | 0001493152-21-027238 |
| 2021-10-28 | S-1/AAmendment | 333-259591 | 0001493152-21-026653 |
| 2021-10-15 | S-1/AAmendment | 333-259591 | 0001493152-21-025617 |
| 2021-10-06 | S-1/AAmendment | 333-259591 | 0001493152-21-024809 |
| 2021-09-17 | S-1Registration filed | 333-259591 | 0001493152-21-022940 |
| 2021-07-20 | DRSDraft made public | 377-05221 | 0001493152-21-017290 |